Guangdong ZhiZhen Biological Medicine Co., Ltd. – Trademark Portfolio
Entity Type: 99
Guangdong ZhiZhen Biological Medicine Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 0 trademarks are registered and 1 is pending. The owner is based in Guangzhou, GuangDong.
No.5 South Street, Datian First Team
Guangzhou, GuangDong 510820 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangdong ZhiZhen Biological Medicine Co., Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Guangdong ZhiZhen Biological Medicine Co., Ltd. have?
Guangdong ZhiZhen Biological Medicine Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 1 pending, 3 abandoned.
What trademark classes does Guangdong ZhiZhen Biological Medicine Co., Ltd. file in?
Guangdong ZhiZhen Biological Medicine Co., Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 3 (Cosmetics & Cleaning). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What is Guangdong ZhiZhen Biological Medicine Co., Ltd.'s trademark registration success rate?
Guangdong ZhiZhen Biological Medicine Co., Ltd. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.